Cutaneous Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Cutaneous Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-04-04Clinical Trial Update: Interobserver Variability Desmoplasia
A clinical trial evaluating interobserver variability in desmoplasia assessment has completed, focusing on cutaneous squamous cell carcinoma…
-
CLINICAL_TRIALS trial_result · 2025-04-04Clinical Trial Update: OCT and Invasion in Cutaneous Skin Lesions
A completed clinical trial from Maastricht University Medical Center evaluating OCT imaging and invasion in cutaneous skin lesions. The stud…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Ph1 Study of SL-172154 Administered Intratumorally in Subjects With Squamous Cell Carcinoma of the Head and Neck or Skin [Phase 1]
Phase 1 intratumoral study of SL-172154 in cutaneous squamous cell carcinoma and squamous cell carcinoma of the head and neck was terminated…
-
CLINICAL_TRIALS trial_result · 2025-02-11Clinical Trial Update: Non-comparative Study of IFX-1 Alone or IFX-1+Pembrolizumab in Patients With Locally Advanced or Metastatic cSCC. [Phase 2]
Phase 2 non-comparative trial evaluating IFX-1 alone or with pembrolizumab in locally advanced or metastatic cutaneous squamous cell carcino…
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: Neoadjuvant Atezolizumab in Surgically Resectable Advanced Cutaneous Squamous Cell Carcinoma [Phase 2]
This update reports results from a Phase 2 neoadjuvant trial of atezolizumab for surgically resectable advanced cutaneous squamous cell carc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: Study of Ruxolitinib in Solid Organ Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma [Phase 2]
A Phase 2 study of ruxolitinib in solid organ transplant recipients with advanced cutaneous squamous cell carcinoma was terminated, and resu…
-
CLINICAL_TRIALS trial_result · 2024-12-11Clinical Trial Update: Study of REGN2810 in Patients With Advanced Cutaneous Squamous Cell Carcinoma [Phase 2]
Phase 2 study of REGN2810 in patients with advanced cutaneous squamous cell carcinoma has completed, with results posted in December 2024.
-
CLINICAL_TRIALS trial_result · 2024-09-23Clinical Trial Update: Immunotherapy With IFx-Hu2.0 Vaccine for Advanced Non-melanoma Skin Cancers [Phase 1]
Phase 1 clinical trial update on the IFx-Hu2.0 vaccine for advanced non-melanoma skin cancers, including Merkel cell carcinoma and cutaneous…
-
CLINICAL_TRIALS trial_result · 2024-08-02Clinical Trial Update: IFx-Hu2.0 for the Treatment of Patients With Skin Cancer [Phase 1]
Phase 1 trial of IFx-Hu2.0 for skin cancers has completed with results posted. The study evaluated IFx-Hu2.0 in patients with Cutaneous Squa…
-
CLINICAL_TRIALS trial_result · 2024-06-26Clinical Trial Update: Pembrolizumab in Patients With Locally Advanced or Metastatic Skin Cancer [Phase 2]
Phase 2 trial of pembrolizumab in locally advanced or metastatic skin cancer has completed. The study included patients with recurrent skin …
-
CLINICAL_TRIALS trial_result · 2024-06-18Clinical Trial Update: Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic [Phase 2]
Phase 2 study of pembrolizumab in patients with rare, unresectable or metastatic solid tumors; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-06-12Clinical Trial Update: Cemiplimab in AlloSCT/SOT Recipients With CSCC [Phase 1, Phase 2]
Phase 1/2 trial of cemiplimab (Libtayo) in recipients of allogeneic stem cell transplant or solid organ transplant with cutaneous squamous c…
-
CLINICAL_TRIALS trial_result · 2023-11-08Clinical Trial Update: Camrelizumab Combined With Cisplatin in the Treatment of Advanced Cutaneous Squamous Cell Carcinoma [Phase 2]
Phase 2 trial evaluating camrelizumab combined with cisplatin for advanced cutaneous squamous cell carcinoma is in an unknown status.
-
CLINICAL_TRIALS trial_result · 2023-10-10Clinical Trial Update: Intratumoral Administration of Daromun in Non-melanoma Skin Cancer Patients [Phase 2]
Phase 2 clinical trial update for intratumoral administration of Daromun in basal cell carcinoma and cutaneous squamous cell carcinoma (non-…
-
CLINICAL_TRIALS trial_result · 2023-06-27Clinical Trial Update: Tacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic Cancers [Phase 1]
Phase 1 trial evaluating the combination of tacrolimus with immune checkpoint inhibitors nivolumab and ipilimumab in kidney transplant recip…
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Study of Cemiplimab in Patients With Type of Skin Cancer Stage II to IV Cutaneous Squamous Cell Carcinoma [Phase 2]
A Phase 2 trial update of cemiplimab in patients with cutaneous squamous cell carcinoma (Stage II to IV) has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2022-07-14Clinical Trial Update: Cemiplimab-rwlc for Unresectable Locally Recurrent and/or Metastatic CSCC [Phase 2]
Phase 2 trial of cemiplimab-rwlc for unresectable locally recurrent and/or metastatic cutaneous squamous cell carcinoma has terminated with …
-
CLINICAL_TRIALS trial_result · 2022-06-21Clinical Trial Update: The Efficacy and Safety of HLX07 in Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma (CSCC) [Phase 2]
Phase 2 trial update evaluating HLX07 for locally advanced or metastatic cutaneous squamous cell carcinoma, with efficacy and safety data no…
-
CLINICAL_TRIALS trial_result · 2021-11-19Clinical Trial Update: Study of Pembrolizumab (MK-3475) in Adults With Recurrent/Metastatic Cutaneous Squamous Cell Carcinoma (cSCC) or Locally Advanced Unresectable cSCC (MK-3475-629/KEYNOTE-629) [Phase 2]
Phase 2 trial of pembrolizumab for adults with recurrent/metastatic or locally advanced unresectable cutaneous squamous cell carcinoma (MK-3…
-
CLINICAL_TRIALS trial_result · 2020-02-12Clinical Trial Update: Nivolumab in Patients With Advanced Cutaneous Squamous Cell Carcinoma [Phase 2]
Phase 2 clinical trial update for nivolumab in patients with advanced cutaneous squamous cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2018-09-11Clinical Trial Update: Immunotherapy +/- EGFR Inhibitor In Advanced/Metastatic cSCC: Tackling Primary And Secondary Resistance [Phase 2]
Phase 2 trial update exploring immunotherapy with or without an EGFR inhibitor in advanced/metastatic cutaneous squamous cell carcinoma (cSC…
-
CLINICAL_TRIALS trial_result · 2018-07-20Clinical Trial Update: Capecitabine or 5-FU With Pegylated Interferon Alpha-2b in Unresectable/Metastatic Cutaneous Squamous Cell Carcinoma [Phase 2]
Phase 2 trial examining capecitabine or 5-FU with pegylated interferon alpha-2b for unresectable/metastatic cutaneous squamous cell carcinom…
-
CLINICAL_TRIALS trial_result · 2017-10-25Clinical Trial Update: Treatment With Nab-paclitaxel in Cutaneous SCC [Phase 2]
A phase 2 trial of nab-paclitaxel for cutaneous squamous cell carcinoma was terminated and results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2016-02-03Clinical Trial Update: New Strategies Against Cutaneous Squamous Cell Carcinoma
This clinical trial update reports the completion of a study investigating new strategies against cutaneous squamous cell carcinoma, sponsor…
-
CLINICAL_TRIALS trial_result · 2013-08-08Clinical Trial Update: A Trial of Erlotinib + Radiotherapy for Cutaneous Squamous Cell Carcinoma [Phase 2]
Phase 2 trial investigating erlotinib in combination with radiotherapy for cutaneous squamous cell carcinoma has completed with results post…